Letter to the editorConfirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts
References (4)
- et al.
Common variable immunodeficiency disorders: division into distinct clinical phenotypes
Blood
(2008) - et al.
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions
Br J Haematol
(2009)
There are more references available in the full text version of this article.
Cited by (111)
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease
2023, Journal of Allergy and Clinical ImmunologyChronic diffuse lung diseases
2022, Practical Pulmonary Pathology: A Diagnostic ApproachHigh Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study
2024, Journal of Clinical ImmunologyImpact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic
2024, Journal of Clinical Immunology
Disclosure of potential conflict of interest: H. Chapel is a board member for Baxter, has consultancy arrangements with Biotest, and has received royalties from Wiley. C. Cunningham-Rundles has consultancy arrangements with Baxter, Grifols, and Merck and has received one or more grants from Octapharma. E. Oksenhendler has received research support from CSL-Bohring and from LFB. The rest of the authors declare that they have no relevant conflicts of interest.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.